Findings seen for offspring evaluated through 24 months postpartum
Many More Lives Could Have Been Saved With Convalescent COVID-19 Plasma
Per a recent study, ideal CCP use could have saved 234,869 lives and prevented 1,136,133 hospitalizations
Shigella Vaccine Candidate Awarded U.S. FDA Fast Track Designation
A seldom-discussed global health threat may soon have a U.S. Food and Drug Administration (FDA)- approved vaccine available.
Valneva SE and LimmaTech Biologics AG today announced that the U.S. FDA has granted Fast Track designation to Shigella4V (S4V), the world's most clinically advanced tetravalent bioconjugate shigellosis vaccine candidate.
Disparities Observed in Mortality During COVID-19 Pandemic
18.3 percent fewer deaths would have occurred had the rate of excess mortality seen in Whites been the same in total population
Risk for Type 2 Diabetes Increased for Children After SARS-CoV-2 Infection
Risk increased in the six months after infection; elevated risk also seen in subpopulation with overweight, obesity and hospitalized patients
Risk for Most Cardiovascular Events Reduced After COVID-19 Vaccination
Increased risk for myocarditis, pericarditis seen one to two weeks after COVID-19 mRNA vaccination
Poll Finds Public Fears Over RSV Have Eased, Although It Remains a Threat
By Dennis Thompson HealthDay ReporterWEDNESDAY, Oct. 16, 2024 (HealthDay News) — Public concerns about contracting RSV (respiratory syncytial virus) have significantly declined during the past year, a new survey shows.About …
Approved Chikungunya Vaccine Confirmed Safe and Effective
As the winter season approaches in the United States, many people plan to vacation in the warmer weather of the Southern Hemisphere this year.
Since mosquitoes actively transmit various diseases in the Caribbean, Central, and South America, protecting yourself with a safe and effective vaccine one month before traveling south is an intelligent goal.
Lithium Aspartate Not Effective for Neurologic Long COVID Fatigue
In subsequent dose-finding study, numerically greater reductions seen in fatigue, cognitive dysfunction scores with 40 to 45 mg/day
Shigella Vaccine Candidate Advancing in Clinical Trials
Shigella, the leading cause of diarrheal deaths worldwide, is having a resurgence in 2024. Among young children, it is estimated that diarrhea caused by Shigella is responsible for about 446,000 deaths globally each year.
In the United States, the Centers for Disease Control and Prevention (CDC) reported 16,498 Shigella cases on October 5, 2024 (Week 40), indicating an 8% increase from 2023.
California (3,483), New York (2,478), and New Jersey (1,446) are leading other states.